Pre-order Enquiry
Request Free Sample
Global Clostridium Difficile Treatment Market Size, Status and Forecast 2021-2027
SKU ID : QYR-19329731 | Publishing Date : 13-Oct-2021 | No. of pages : 118
Detailed TOC of Global Clostridium Difficile Treatment Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clostridium Difficile Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Narrow Spectrum Antibiotics
1.2.3 Broad Spectrum Antibiotics
1.3 Market by Application
1.3.1 Global Clostridium Difficile Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Clostridium Difficile Treatment Market Perspective (2016-2027)
2.2 Clostridium Difficile Treatment Growth Trends by Regions
2.2.1 Clostridium Difficile Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Clostridium Difficile Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Clostridium Difficile Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Clostridium Difficile Treatment Industry Dynamic
2.3.1 Clostridium Difficile Treatment Market Trends
2.3.2 Clostridium Difficile Treatment Market Drivers
2.3.3 Clostridium Difficile Treatment Market Challenges
2.3.4 Clostridium Difficile Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clostridium Difficile Treatment Players by Revenue
3.1.1 Global Top Clostridium Difficile Treatment Players by Revenue (2016-2021)
3.1.2 Global Clostridium Difficile Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Clostridium Difficile Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Clostridium Difficile Treatment Revenue
3.4 Global Clostridium Difficile Treatment Market Concentration Ratio
3.4.1 Global Clostridium Difficile Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clostridium Difficile Treatment Revenue in 2020
3.5 Clostridium Difficile Treatment Key Players Head office and Area Served
3.6 Key Players Clostridium Difficile Treatment Product Solution and Service
3.7 Date of Enter into Clostridium Difficile Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Clostridium Difficile Treatment Breakdown Data by Type
4.1 Global Clostridium Difficile Treatment Historic Market Size by Type (2016-2021)
4.2 Global Clostridium Difficile Treatment Forecasted Market Size by Type (2022-2027)
5 Clostridium Difficile Treatment Breakdown Data by Application
5.1 Global Clostridium Difficile Treatment Historic Market Size by Application (2016-2021)
5.2 Global Clostridium Difficile Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Clostridium Difficile Treatment Market Size (2016-2027)
6.2 North America Clostridium Difficile Treatment Market Size by Type
6.2.1 North America Clostridium Difficile Treatment Market Size by Type (2016-2021)
6.2.2 North America Clostridium Difficile Treatment Market Size by Type (2022-2027)
6.2.3 North America Clostridium Difficile Treatment Market Size by Type (2016-2027)
6.3 North America Clostridium Difficile Treatment Market Size by Application
6.3.1 North America Clostridium Difficile Treatment Market Size by Application (2016-2021)
6.3.2 North America Clostridium Difficile Treatment Market Size by Application (2022-2027)
6.3.3 North America Clostridium Difficile Treatment Market Size by Application (2016-2027)
6.4 North America Clostridium Difficile Treatment Market Size by Country
6.4.1 North America Clostridium Difficile Treatment Market Size by Country (2016-2021)
6.4.2 North America Clostridium Difficile Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Clostridium Difficile Treatment Market Size (2016-2027)
7.2 Europe Clostridium Difficile Treatment Market Size by Type
7.2.1 Europe Clostridium Difficile Treatment Market Size by Type (2016-2021)
7.2.2 Europe Clostridium Difficile Treatment Market Size by Type (2022-2027)
7.2.3 Europe Clostridium Difficile Treatment Market Size by Type (2016-2027)
7.3 Europe Clostridium Difficile Treatment Market Size by Application
7.3.1 Europe Clostridium Difficile Treatment Market Size by Application (2016-2021)
7.3.2 Europe Clostridium Difficile Treatment Market Size by Application (2022-2027)
7.3.3 Europe Clostridium Difficile Treatment Market Size by Application (2016-2027)
7.4 Europe Clostridium Difficile Treatment Market Size by Country
7.4.1 Europe Clostridium Difficile Treatment Market Size by Country (2016-2021)
7.4.2 Europe Clostridium Difficile Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Clostridium Difficile Treatment Market Size (2016-2027)
8.2 Asia-Pacific Clostridium Difficile Treatment Market Size by Type
8.2.1 Asia-Pacific Clostridium Difficile Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Clostridium Difficile Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Clostridium Difficile Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Clostridium Difficile Treatment Market Size by Application
8.3.1 Asia-Pacific Clostridium Difficile Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Clostridium Difficile Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Clostridium Difficile Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Clostridium Difficile Treatment Market Size by Region
8.4.1 Asia-Pacific Clostridium Difficile Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Clostridium Difficile Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Clostridium Difficile Treatment Market Size (2016-2027)
9.2 Latin America Clostridium Difficile Treatment Market Size by Type
9.2.1 Latin America Clostridium Difficile Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Clostridium Difficile Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Clostridium Difficile Treatment Market Size by Type (2016-2027)
9.3 Latin America Clostridium Difficile Treatment Market Size by Application
9.3.1 Latin America Clostridium Difficile Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Clostridium Difficile Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Clostridium Difficile Treatment Market Size by Application (2016-2027)
9.4 Latin America Clostridium Difficile Treatment Market Size by Country
9.4.1 Latin America Clostridium Difficile Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Clostridium Difficile Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clostridium Difficile Treatment Market Size (2016-2027)
10.2 Middle East & Africa Clostridium Difficile Treatment Market Size by Type
10.2.1 Middle East & Africa Clostridium Difficile Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Clostridium Difficile Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Clostridium Difficile Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Clostridium Difficile Treatment Market Size by Application
10.3.1 Middle East & Africa Clostridium Difficile Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Clostridium Difficile Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Clostridium Difficile Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Clostridium Difficile Treatment Market Size by Country
10.4.1 Middle East & Africa Clostridium Difficile Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Clostridium Difficile Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Actelion Pharmaceuticals
11.1.1 Actelion Pharmaceuticals Company Details
11.1.2 Actelion Pharmaceuticals Business Overview
11.1.3 Actelion Pharmaceuticals Clostridium Difficile Treatment Introduction
11.1.4 Actelion Pharmaceuticals Revenue in Clostridium Difficile Treatment Business (2016-2021)
11.1.5 Actelion Pharmaceuticals Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Clostridium Difficile Treatment Introduction
11.2.4 Merck Revenue in Clostridium Difficile Treatment Business (2016-2021)
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Clostridium Difficile Treatment Introduction
11.3.4 Pfizer Revenue in Clostridium Difficile Treatment Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Summit Therapeutics
11.4.1 Summit Therapeutics Company Details
11.4.2 Summit Therapeutics Business Overview
11.4.3 Summit Therapeutics Clostridium Difficile Treatment Introduction
11.4.4 Summit Therapeutics Revenue in Clostridium Difficile Treatment Business (2016-2021)
11.4.5 Summit Therapeutics Recent Development
11.5 Astellas Pharma
11.5.1 Astellas Pharma Company Details
11.5.2 Astellas Pharma Business Overview
11.5.3 Astellas Pharma Clostridium Difficile Treatment Introduction
11.5.4 Astellas Pharma Revenue in Clostridium Difficile Treatment Business (2016-2021)
11.5.5 Astellas Pharma Recent Development
11.6 CRESTOVO
11.6.1 CRESTOVO Company Details
11.6.2 CRESTOVO Business Overview
11.6.3 CRESTOVO Clostridium Difficile Treatment Introduction
11.6.4 CRESTOVO Revenue in Clostridium Difficile Treatment Business (2016-2021)
11.6.5 CRESTOVO Recent Development
11.7 Da Volterra
11.7.1 Da Volterra Company Details
11.7.2 Da Volterra Business Overview
11.7.3 Da Volterra Clostridium Difficile Treatment Introduction
11.7.4 Da Volterra Revenue in Clostridium Difficile Treatment Business (2016-2021)
11.7.5 Da Volterra Recent Development
11.8 Immuron
11.8.1 Immuron Company Details
11.8.2 Immuron Business Overview
11.8.3 Immuron Clostridium Difficile Treatment Introduction
11.8.4 Immuron Revenue in Clostridium Difficile Treatment Business (2016-2021)
11.8.5 Immuron Recent Development
11.9 MGB Biopharma
11.9.1 MGB Biopharma Company Details
11.9.2 MGB Biopharma Business Overview
11.9.3 MGB Biopharma Clostridium Difficile Treatment Introduction
11.9.4 MGB Biopharma Revenue in Clostridium Difficile Treatment Business (2016-2021)
11.9.5 MGB Biopharma Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Clostridium Difficile Treatment Introduction
11.10.4 Novartis Revenue in Clostridium Difficile Treatment Business (2016-2021)
11.10.5 Novartis Recent Development
11.11 Otsuka Pharmaceutical
11.11.1 Otsuka Pharmaceutical Company Details
11.11.2 Otsuka Pharmaceutical Business Overview
11.11.3 Otsuka Pharmaceutical Clostridium Difficile Treatment Introduction
11.11.4 Otsuka Pharmaceutical Revenue in Clostridium Difficile Treatment Business (2016-2021)
11.11.5 Otsuka Pharmaceutical Recent Development
11.12 Rebiotix
11.12.1 Rebiotix Company Details
11.12.2 Rebiotix Business Overview
11.12.3 Rebiotix Clostridium Difficile Treatment Introduction
11.12.4 Rebiotix Revenue in Clostridium Difficile Treatment Business (2016-2021)
11.12.5 Rebiotix Recent Development
11.13 Romark Laboratories
11.13.1 Romark Laboratories Company Details
11.13.2 Romark Laboratories Business Overview
11.13.3 Romark Laboratories Clostridium Difficile Treatment Introduction
11.13.4 Romark Laboratories Revenue in Clostridium Difficile Treatment Business (2016-2021)
11.13.5 Romark Laboratories Recent Development
11.14 Sanofi Pasteur
11.14.1 Sanofi Pasteur Company Details
11.14.2 Sanofi Pasteur Business Overview
11.14.3 Sanofi Pasteur Clostridium Difficile Treatment Introduction
11.14.4 Sanofi Pasteur Revenue in Clostridium Difficile Treatment Business (2016-2021)
11.14.5 Sanofi Pasteur Recent Development
11.15 Seres Therapeutics
11.15.1 Seres Therapeutics Company Details
11.15.2 Seres Therapeutics Business Overview
11.15.3 Seres Therapeutics Clostridium Difficile Treatment Introduction
11.15.4 Seres Therapeutics Revenue in Clostridium Difficile Treatment Business (2016-2021)
11.15.5 Seres Therapeutics Recent Development
11.16 Takeda
11.16.1 Takeda Company Details
11.16.2 Takeda Business Overview
11.16.3 Takeda Clostridium Difficile Treatment Introduction
11.16.4 Takeda Revenue in Clostridium Difficile Treatment Business (2016-2021)
11.16.5 Takeda Recent Development
11.17 Synthetic Biologics
11.17.1 Synthetic Biologics Company Details
11.17.2 Synthetic Biologics Business Overview
11.17.3 Synthetic Biologics Clostridium Difficile Treatment Introduction
11.17.4 Synthetic Biologics Revenue in Clostridium Difficile Treatment Business (2016-2021)
11.17.5 Synthetic Biologics Recent Development
11.18 Bausch Health
11.18.1 Bausch Health Company Details
11.18.2 Bausch Health Business Overview
11.18.3 Bausch Health Clostridium Difficile Treatment Introduction
11.18.4 Bausch Health Revenue in Clostridium Difficile Treatment Business (2016-2021)
11.18.5 Bausch Health Recent Development
11.18 Valneva
.1 Valneva Company Details
.2 Valneva Business Overview
.3 Valneva Clostridium Difficile Treatment Introduction
.4 Valneva Revenue in Clostridium Difficile Treatment Business (2016-2021)
.5 Valneva Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Clostridium Difficile Treatment Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Clostridium Difficile Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Narrow Spectrum Antibiotics
Table 3. Key Players of Broad Spectrum Antibiotics
Table 4. Global Clostridium Difficile Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Clostridium Difficile Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Clostridium Difficile Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Clostridium Difficile Treatment Market Share by Regions (2016-2021)
Table 8. Global Clostridium Difficile Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Clostridium Difficile Treatment Market Share by Regions (2022-2027)
Table 10. Clostridium Difficile Treatment Market Trends
Table 11. Clostridium Difficile Treatment Market Drivers
Table 12. Clostridium Difficile Treatment Market Challenges
Table 13. Clostridium Difficile Treatment Market Restraints
Table 14. Global Clostridium Difficile Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Clostridium Difficile Treatment Market Share by Players (2016-2021)
Table 16. Global Top Clostridium Difficile Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clostridium Difficile Treatment as of 2020)
Table 17. Ranking of Global Top Clostridium Difficile Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Clostridium Difficile Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Clostridium Difficile Treatment Product Solution and Service
Table 21. Date of Enter into Clostridium Difficile Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Clostridium Difficile Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Clostridium Difficile Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Clostridium Difficile Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Clostridium Difficile Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Clostridium Difficile Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Clostridium Difficile Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Clostridium Difficile Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Clostridium Difficile Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Clostridium Difficile Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Clostridium Difficile Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Clostridium Difficile Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Clostridium Difficile Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Clostridium Difficile Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Clostridium Difficile Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Clostridium Difficile Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Clostridium Difficile Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Clostridium Difficile Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Clostridium Difficile Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Clostridium Difficile Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Clostridium Difficile Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Clostridium Difficile Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Clostridium Difficile Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Clostridium Difficile Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Clostridium Difficile Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Clostridium Difficile Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Clostridium Difficile Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Clostridium Difficile Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Clostridium Difficile Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Clostridium Difficile Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Clostridium Difficile Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Clostridium Difficile Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Clostridium Difficile Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Clostridium Difficile Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Clostridium Difficile Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Clostridium Difficile Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Clostridium Difficile Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Clostridium Difficile Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Clostridium Difficile Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Actelion Pharmaceuticals Company Details
Table 62. Actelion Pharmaceuticals Business Overview
Table 63. Actelion Pharmaceuticals Clostridium Difficile Treatment Product
Table 64. Actelion Pharmaceuticals Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million)
Table 65. Actelion Pharmaceuticals Recent Development
Table 66. Merck Company Details
Table 67. Merck Business Overview
Table 68. Merck Clostridium Difficile Treatment Product
Table 69. Merck Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million)
Table 70. Merck Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Clostridium Difficile Treatment Product
Table 74. Pfizer Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Summit Therapeutics Company Details
Table 77. Summit Therapeutics Business Overview
Table 78. Summit Therapeutics Clostridium Difficile Treatment Product
Table 79. Summit Therapeutics Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million)
Table 80. Summit Therapeutics Recent Development
Table 81. Astellas Pharma Company Details
Table 82. Astellas Pharma Business Overview
Table 83. Astellas Pharma Clostridium Difficile Treatment Product
Table 84. Astellas Pharma Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million)
Table 85. Astellas Pharma Recent Development
Table 86. CRESTOVO Company Details
Table 87. CRESTOVO Business Overview
Table 88. CRESTOVO Clostridium Difficile Treatment Product
Table 89. CRESTOVO Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million)
Table 90. CRESTOVO Recent Development
Table 91. Da Volterra Company Details
Table 92. Da Volterra Business Overview
Table 93. Da Volterra Clostridium Difficile Treatment Product
Table 94. Da Volterra Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million)
Table 95. Da Volterra Recent Development
Table 96. Immuron Company Details
Table 97. Immuron Business Overview
Table 98. Immuron Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million)
Table 99. Immuron Recent Development
Table 100. MGB Biopharma Company Details
Table 101. MGB Biopharma Business Overview
Table 102. MGB Biopharma Clostridium Difficile Treatment Product
Table 103. MGB Biopharma Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million)
Table 104. MGB Biopharma Recent Development
Table 105. Novartis Company Details
Table 106. Novartis Business Overview
Table 107. Novartis Clostridium Difficile Treatment Product
Table 108. Novartis Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million)
Table 109. Novartis Recent Development
Table 110. Otsuka Pharmaceutical Company Details
Table 111. Otsuka Pharmaceutical Business Overview
Table 112. Otsuka Pharmaceutical Clostridium Difficile Treatment Product
Table 113. Otsuka Pharmaceutical Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million)
Table 114. Otsuka Pharmaceutical Recent Development
Table 115. Rebiotix Company Details
Table 116. Rebiotix Business Overview
Table 117. Rebiotix Clostridium Difficile Treatment Product
Table 118. Rebiotix Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million)
Table 119. Rebiotix Recent Development
Table 120. Romark Laboratories Company Details
Table 121. Romark Laboratories Business Overview
Table 122. Romark Laboratories Clostridium Difficile Treatment Product
Table 123. Romark Laboratories Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million)
Table 124. Romark Laboratories Recent Development
Table 125. Sanofi Pasteur Company Details
Table 126. Sanofi Pasteur Business Overview
Table 127. Sanofi Pasteur Clostridium Difficile Treatment Product
Table 128. Sanofi Pasteur Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million)
Table 129. Sanofi Pasteur Recent Development
Table 130. Seres Therapeutics Company Details
Table 131. Seres Therapeutics Business Overview
Table 132. Seres Therapeutics Clostridium Difficile Treatment Product
Table 133. Seres Therapeutics Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million)
Table 134. Seres Therapeutics Recent Development
Table 135. Takeda Company Details
Table 136. Takeda Business Overview
Table 137. Takeda Clostridium Difficile Treatment Product
Table 138. Takeda Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million)
Table 139. Takeda Recent Development
Table 140. Synthetic Biologics Company Details
Table 141. Synthetic Biologics Business Overview
Table 142. Synthetic Biologics Clostridium Difficile Treatment Product
Table 143. Synthetic Biologics Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million)
Table 144. Synthetic Biologics Recent Development
Table 145. Bausch Health Company Details
Table 146. Bausch Health Business Overview
Table 147. Bausch Health Clostridium Difficile Treatment Product
Table 148. Bausch Health Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million)
Table 149. Bausch Health Recent Development
Table 150. Valneva Company Details
Table 151. Valneva Business Overview
Table 152. Valneva Clostridium Difficile Treatment Product
Table 153. Valneva Revenue in Clostridium Difficile Treatment Business (2016-2021) & (US$ Million)
Table 154. Valneva Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Clostridium Difficile Treatment Market Share by Type: 2020 VS 2027
Figure 2. Narrow Spectrum Antibiotics Features
Figure 3. Broad Spectrum Antibiotics Features
Figure 4. Global Clostridium Difficile Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Clostridium Difficile Treatment Report Years Considered
Figure 9. Global Clostridium Difficile Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Clostridium Difficile Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Clostridium Difficile Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Clostridium Difficile Treatment Market Share by Regions (2022-2027)
Figure 13. Global Clostridium Difficile Treatment Market Share by Players in 2020
Figure 14. Global Top Clostridium Difficile Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clostridium Difficile Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Clostridium Difficile Treatment Revenue in 2020
Figure 16. Global Clostridium Difficile Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Clostridium Difficile Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Clostridium Difficile Treatment Market Share by Type (2016-2027)
Figure 20. North America Clostridium Difficile Treatment Market Share by Application (2016-2027)
Figure 21. North America Clostridium Difficile Treatment Market Share by Country (2016-2027)
Figure 22. United States Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Clostridium Difficile Treatment Market Share by Type (2016-2027)
Figure 26. Europe Clostridium Difficile Treatment Market Share by Application (2016-2027)
Figure 27. Europe Clostridium Difficile Treatment Market Share by Country (2016-2027)
Figure 28. Germany Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Clostridium Difficile Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Clostridium Difficile Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Clostridium Difficile Treatment Market Share by Region (2016-2027)
Figure 38. China Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Clostridium Difficile Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Clostridium Difficile Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Clostridium Difficile Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Clostridium Difficile Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Clostridium Difficile Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Clostridium Difficile Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Clostridium Difficile Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Actelion Pharmaceuticals Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021)
Figure 58. Merck Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021)
Figure 60. Summit Therapeutics Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021)
Figure 61. Astellas Pharma Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021)
Figure 62. CRESTOVO Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021)
Figure 63. Da Volterra Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021)
Figure 64. Immuron Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021)
Figure 65. MGB Biopharma Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021)
Figure 67. Otsuka Pharmaceutical Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021)
Figure 68. Rebiotix Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021)
Figure 69. Romark Laboratories Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021)
Figure 70. Sanofi Pasteur Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021)
Figure 71. Seres Therapeutics Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021)
Figure 72. Takeda Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021)
Figure 73. Synthetic Biologics Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021)
Figure 74. Bausch Health Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021)
Figure 75. Valneva Revenue Growth Rate in Clostridium Difficile Treatment Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
Keyplayers in Global Clostridium Difficile Treatment Market Size, Status and Forecast 2021-2027
Actelion PharmaceuticalsMerck
Pfizer
Summit Therapeutics
Astellas Pharma
CRESTOVO
Da Volterra
Immuron
MGB Biopharma
Novartis
Otsuka Pharmaceutical
Rebiotix
Romark Laboratories
Sanofi Pasteur
Seres Therapeutics
Takeda
Synthetic Biologics
Bausch Health
Valneva
Request Sample
Request Discount
